About us
Pipeline
Target Markets
Our Technologies
Partnering
News, Media & Events
Investors
Careers
Contact
Home
News, Media & Events
Media Coverage
Destiny Pharma consultant Professor Dale Gerding updates on recurrent C. difficile infections work
Destiny Pharma consultant Professor Dale Gerding updates on recurrent C. difficile infections work